Anish John
2023
In 2023, Anish John earned a total compensation of $449.2K as Former Chief Financial Officer at Oncocyte Corp, a 39% decrease compared to previous year.
Compensation breakdown
| Option Awards | $97,198 |
|---|---|
| Salary | $147,138 |
| Other | $204,826 |
| Total | $449,161 |
John received $204.8K in other compensation, accounting for 46% of the total pay in 2023.
John also received $97.2K in option awards and $147.1K in salary.
Rankings
In 2023, Anish John's compensation ranked 2,159th out of 2,983 executives tracked by ExecPay. In other words, John earned more than 27.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,159 out of 2,983 | 28th |
Division Manufacturing | 1,223 out of 1,637 | 25th |
Major group Chemicals And Allied Products | 735 out of 906 | 19th |
Industry group Drugs | 717 out of 869 | 18th |
Industry In Vitro and In Vivo Diagnostic Substances | 8 out of 14 | 43rd |
Source: SEC filing on April 29, 2024.
John's colleagues
We found three more compensation records of executives who worked with Anish John at Oncocyte Corp in 2023.